Transvaginal Mesh Trial Testimony Suggests Inherent Hazards in Implanted Mesh Material, Reports Audet and Partners, LLP
San Francisco, CA (PRWEB) August 07, 2013 -- The first trial against C.R. Bard, Inc. alleging injuries stemming from its Avaulta Plus transvaginal mesh product has entered its second week in a West Virginia federal court. The case, Cisson, et. al. v. C.R. Bard, Inc., Case No. 2:11-cv-00195 brought in the United States District Court for the Southern District of West Virginia, Charleston Division, alleges that implantation of the Avaulta Plus product led to permanent injury in the plaintiff who had undergone surgery to treat pelvic organ prolapse.*
The manufacturer of the devices had warned Bard that the polypropylene material from which the device is made is not suitable for implementation in the human body.**
During the trial late last week, a videotaped deposition of Douglas Evans, a Bard engineer was played to the jury during which Mr. Evans noted that:
"Although some doctors are satisfied with the results they’ve achieved with synthetic sling kits, some doctors prefer not to use them due to potential infection, urethral or vaginal wall erosion because the mesh … (can) unravel, creating a fishing line effect, slicing through the patient’s tissue."*
Additionally, an expert in materials science, Anthony Brennan, Ph.D. testified that the polypropylene material, once introduced into the human body, is prone to degradation during which particles of the device may be released into the body.* The introduction of these foreign particles into the human body may lead to dangerous inflammation and other deleterious side effects.* Dr. Brennan further noted that cutting or trimming the mesh during surgery, allegedly a common practice among surgeons, can hasten material degradation and potentially exacerbate negative complications.***
Attorney William Audet, whose San Francisco-based law firm represents several individual plaintiffs alleging injuries caused by transvaginal mesh implantation notes that concerns raised during last week's testimony parallel problems experienced by his clients. "We continue to speak with several clients every week with serious internal complications related to transvaginal mesh implants. The testimony regarding the tendency of polypropylene to degrade when implanted in the human body may well provide an explanation as to why so many of our clients appear to have emerged from transvaginal mesh surgery in far worse condition than they appeared to be prior to the surgery."
If you, or one close to you, has suffered injuries that may be related to transvaginal mesh, you are urged to contact Audet and Partners, LLP for a free case evaluation at (800) 965-1461, or visit our dedicated website at http://www.vaginalmeshlaws.com.
William Audet, J.D., L.L.M., Audet and Partners, LLP, http://www.audetlaw.com, (800) 965-1461, [email protected]
Share this article